Shanghai Institute of Planned Parenthood Research

The Shanghai Institute of Planned Parenthood Research (SIPPR) is a premier research institution in China dedicated to reproductive health and family planning technologies. Founded in 1978, it has evolved into a comprehensive R&D center that covers basic research, applied development, and clinical evaluation of contraceptives and reproductive medicines. In 2020, it was integrated into the Shanghai Institute for Biomedical Pharmaceutical Technologies (SIBPT) to enhance its biopharmaceutical capabilities. SIPPR serves as a World Health Organization (WHO) Collaborating Centre for Research in Human Reproduction, maintaining high international standards in its scientific output. The institute's portfolio includes significant advancements in hormonal contraceptives, intrauterine devices, and treatments for infertility. It also provides specialized CRO and CMO services, including GLP-compliant toxicology and GMP-certified manufacturing for reproductive health products.